These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 39135125)

  • 1. Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.
    Whitehall KB; Rose S; Clague GE; Ahring KK; Bilder DA; Harding CO; Hermida Á; Inwood A; Longo N; Maillot F; Muntau AC; Pessoa ALS; Rocha JC; Rohr F; Sivri S; Said J; Oshinbolu S; Sibbring GC
    Orphanet J Rare Dis; 2024 Aug; 19(1):293. PubMed ID: 39135125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria.
    Zori R; Ahring K; Burton B; Pastores GM; Rutsch F; Jha A; Jurecki E; Rowell R; Harding C
    Mol Genet Metab; 2019; 128(1-2):92-101. PubMed ID: 31439512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
    Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
    Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis.
    Rodrigues C; Pinto A; Faria A; Teixeira D; van Wegberg AMJ; Ahring K; Feillet F; Calhau C; MacDonald A; Moreira-Rosário A; Rocha JC
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial.
    Ten Hoedt AE; Hollak CE; Boelen CC; van der Herberg-van de Wetering NA; Ter Horst NM; Jonkers CF; Wijburg FA; Bosch AM
    Orphanet J Rare Dis; 2011 Jun; 6():48. PubMed ID: 21708003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
    Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
    Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data.
    Rohr F; Burton B; Dee A; Harding CO; Lilienstein J; Lindstrom K; MacLeod E; Rose S; Singh R; van Calcar S; Whitehall K
    Mol Genet Metab; 2024 Mar; 141(3):108122. PubMed ID: 38184920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry.
    Kenneson A; Singh RH
    Mol Genet Metab; 2021 Nov; 134(3):243-249. PubMed ID: 34654619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the nutritional and pharmacological management of phenylketonuria.
    Ney DM; Blank RD; Hansen KE
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
    Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands.
    Eijgelshoven I; Demirdas S; Smith TA; van Loon JM; Latour S; Bosch AM
    Mol Genet Metab; 2013 Jul; 109(3):237-42. PubMed ID: 23731533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Investigation of Microbiome and Dietary Differences in Patients with Phenylketonuria on Enzyme Substitution Therapy Compared to Traditional Therapies.
    McWhorter N; Dhillon J; Hoffman J
    J Acad Nutr Diet; 2022 Jul; 122(7):1283-1295.e3. PubMed ID: 34968752
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.